Vol 2022, No 1 (2022)

Table of Contents

Research & Development

Sumitomo Dainippon Enters Neurology Partnership with Otsuka Pharmaceuticals for US$890 M Abstract pdf html
Swati Sharan
Pfizer Collaborates with Beam on Gene Editing Technology Abstract pdf html
Lucy Haggerty
Eli Lilly Bolsters Metabolic Portfolio with Evotec and Abbisko Collaborations Abstract pdf html
Lucy Haggerty

Licensing

Genmab Licenses Synaffix’s Antibody-Drug Conjugate Technologies Abstract pdf html
Lucy Haggerty

Mergers & Acquisitions

Takeda Exercises Option to Acquire Adaptate Biotherapeutics Abstract pdf html
Sasha Yachu

Opinion & Analysis

M&A Activity in 2021 Ends with a Bang Abstract pdf html
Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.